Research

Next generation sequencing (NGS) testing detects UBA1 gene mutations, which are essential for the diagnosis of VEXAS syndrome and concurrent hematologic neoplasms.

ARUP medical directors will present key hematopathology research at the 66th ASH Annual Meeting, including developments in systemic mastocytosis treatment and testing for myeloid malignancy mutations.

ARUP medical directors and scientists presented key molecular pathology advancements at AMP 2024 on topics such as viral load prediction, automated DNA extraction, and parasite detection.

A new, first-of-its-kind test uses blood-based biomarkers to assess the risk of developing preeclampsia with severe features and facilitates appropriate interventions.

Benjamin T. Bradley, MD, PhD, was awarded a grant to study the use of a self-collection blood sample device to increase access to hepatitis C virus testing in rural Utah counties.

ARUP medical directors will present at the 2024 Association of Medical Laboratory Immunologists (AMLI) Annual Meeting on emerging topics in the field.

The new Sherrie Perkins Research and Innovation Collaboration Grant, designed to foster collaboration in healthcare, will fund cutting-edge research in lab medicine that could impact patient care.

ARUP experts will present at ASM Microbe 2024 on emerging topics in infectious disease, including parasitology, mycobacterial infections, and more.

Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to comply.

ARUP medical directors and scientists will discuss the latest in pharmacogenomics, RNA sequencing, and laboratory genetics career pathways at the upcoming ACMG Annual Clinical Genetics Meeting.